Trial Summary
What is the purpose of this trial?The purpose of this section is to learn how text message reminders might help with regularly taking chemotherapy medications for Adolescents and Young Adults (AYA) with Acute Lymphoblastic leukemia (ALL).
Eligibility Criteria
This trial is for young people aged 15-39 who were diagnosed with Acute Lymphoblastic Leukemia (ALL) and are starting maintenance treatment that includes mercaptopurine and methotrexate. They must want to participate and have a cell phone capable of receiving text messages.Inclusion Criteria
I have been diagnosed with Acute Lymphoblastic Leukemia (ALL).
I was diagnosed with ALL between the ages of 15 and 39.
I am starting maintenance treatment with mercaptopurine and methotrexate.
Exclusion Criteria
I do not want to join the clinical trial.
Patient or caregiver who would receive text message reminders does not have a cell phone that receives text messages
Participant Groups
The study tests if text message reminders can help adolescents and young adults take their oral chemotherapy medications more consistently. Participants will receive either high intensity, low intensity, or no text messaging as part of the intervention.
2Treatment groups
Active Control
Group I: High IntensityActive Control1 Intervention
Receives high-intensity text messaging for 2 cycles of treatment
Group II: Low IntensityActive Control2 Interventions
Receives no texts for 1st cycle and low-intensity texts for 2nd cycle
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
University of Chicago Medicine Comprehensive Cancer CenterChicago, IL
Loading ...
Who Is Running the Clinical Trial?
University of ChicagoLead Sponsor